Early warning triad for pulmonary microemboli in COVID-19 pneumonia: Pulmonary artery diameter, D-dimer and NT-proBNP

Early warning triad for pulmonary microemboli in COVID-19 pneumonia: Pulmonary artery diameter, D-dimer and NT-proBNP

Blog Article

In COVID-19 patients, thrombotic and fibrinolytic events due to hyperinflammation coexist.This causes enlargement of the pulmonary artery trunk, increased D-dimer and proBNP new belial model levels.We studied the correlation of PAD, D-dimer, and NT-proBNP levels.

We saw that microemboli can be predicted by using this correlation.908 patients treated due to Covid-19 were included in the study.The patients were divided into two groups as survivors and mortal and divided into 4 groups according to lung involvement.

Demographic, laboratory, and CT data were obtained from the hospital data recording system.When comparing inflammatory parameters, D-Dimer, PAD, NT-proBNP levels, we detected a significant difference between groups.There was a positive correlation between D-dimer, PAD, and NT-proBNP levels.

Lung involvement more than 50% significantly increased mortality.The diagnosis of PE in patients with COVID-19 has vital importance.Rapid, reliable, non-invasive, easily accessible and low-cost tests are important in diagnosis.

We predict that PAD and concurrent D-dimer with NT-proBNP elevation will enable earlier cga 200 to cga 510 adapter detection of pulmonary microemboli, determine mortality and prognosis, and help to regulate anticoagulation treatments earlier.[Med-Science 2022; 11(2.000): 775-9].